Bernoulli’s John Zaleski and Jeanne Venella co-author respiratory depression study in Biomedical Instrumentation & Technology

Bernoulli’s John Zaleski and Jeanne Venella co-author respiratory depression study in Biomedical Instrumentation & TechnologyJohn Zaleski, PhD, CAP, CPHIMS, Chief Analytics Officer, and Jeanne Venella, DNP, MS, RN, CEN, CPEN, Chief Nursing Officer of Bernoulli, the real-time leader in patient safety, co-authored a study demonstrating the use of patented analytics, medical device connectivity and combinatorial alarms to provide remote centralized continuous monitoring of post-surgical patients at risk for opioid-induced respiratory depression (OIRD).

The peer-reviewed study—Continuous Surveillance of Sleep Apnea Patients in a Medical-Surgical Unit—published in the May/June 2017 issue of Biomedical Instrumentation & Technology, consists of two separate studies on the use of continuous capnography monitoring at a medical-surgical unit at Virtua Health System in New Jersey.

The study’s results suggest that combinatorial alarm signals based on multi-parameter assessment reduced overall load better than individual-parameter sustained alarm signals and appeared to be more effective at identifying at-risk patients.

Using only sustained alarms as the filter for notifications reduced alerts from 22,812 to 13,000. However, passing multiple series of data through a multi-variable rules engine that monitored the values of pulse (HR), oxygen saturation (SpO2), respiratory rate (RR), and end-tidal carbon dioxide (ETCO2) in order to determine which alarms to send to the nurse-call phone system further reduced alerts to just 209—a 99% reduction.

The solution

The solution leveraged in the study, Bernoulli’s Respiratory Depression Safety Surveillance, includes patented analytics with multi-variable thresholds—adjustable by the care facility—to identify clinically actionable events while significantly reducing the overall number of alarms communicated to remote and mobile clinicians, mitigating the risk of alarm fatigue.

The study’s other co-authors include Dana Supe, MD, MBA, DABSM; Leah Baron, MD; Tom Decker; and Kyle Parker of Virtua, and Kari Beaton, RN, and Sarah Williams, RT, of Bernoulli.

Access the May/June 2017 issue of Biomedical Instrumentation & Technology here.

Follow Bernoulli on LinkedIn and Twitter for the latest news and updates.

patient monitoring article in rt magazine alarm management

John Zaleski featured in RT Magazine cover story on alarm management for respiratory therapists

John Zaleski, PhD, CAP, CPHIMS, Chief Analytics Officer of Bernoulli, the real-time leader in patient safety, is featured in the May/June cover story of RT Magazine, “Patient Monitoring and Alarm Fatigue.”

The article notes that alarm fatigue continues to remain a significant patient safety threat and details how clinicians can mitigate this problem.

Zaleski says that hospitals and health systems need better understanding of their current state environment, including clinical workflows, patient cohorts, and assessments in order to develop comprehensive guidelines and protocols for clinical alarm management.

As for solutions, Zaleski recommends one with integration capabilities. “Combinatorial alarms take multiple sources of information and bring it together to corroborate events. This is not simply limited to data extracted in real time from patient care devices at the point of care, but also can be drawn from ancillary sources.”

Read the cover story here. A case study on Bernoulli’s success in ventilator alarm management at the Hospital for Special Care is available here.

Be sure to also follow Bernoulli on LinkedIn and Twitter for the latest news and updates.

Bernoulli will be exhibiting at the AAMI Conference and Expo booth #1226

AAMI 2017 conference

Bernoulli will be exhibiting at the AAMI Conference and Expo.

Bernoulli will be exhibiting at the AAMI Conference and Expo. The conference is in Austin, Texas from June 9th to 12th; Bernoulli will be in booth # 1226.

The conference has long been well known as the place where innovation, connection, and advancement in medical technologies come together. It is where the very best and the very brightest join together to exchange ideas on better performance, service, improved patient safety, and better quality of life in the medical industry.

At the AAMI Conference and Expo Bernoulli One™ the company’s flagship platform will show that better results in allocation of personnel resources at reduced support costs is not only a possibility but also a reality.

Bernoulli One™ is a connected, end to end, powerful and predictive capability in analytics, robust distribution, advanced alarm management, clinical surveillance and more, all in one solution.

About Bernoulli

Bernoulli is the industry’s premier leader in real time, real life, patient care monitoring systems and data. That is because the people at Bernoulli intuitively know that a patient’s care, their safety and well being, and their continued health is their most important priority. Their efforts in dynamically programmable intelligent appliances for control, connectivity, monitoring and management reflect that.

Friendly service, professional advice, and direct answers will be on hand at the conference to help provide the solutions to improving patient safer in in real time. For more information on how we can help you please follow the link Bernoullihealth.com

For additional information on the conference go to: http://www.aami.org/annualconference/

virtua case study detailing Bernoulli One successful medical device integration and connectivity

Bernoulli case study details multi-hospital medical device connectivity

Bernoulli, the real-time leader in patient safety, has published a new case study detailing its successful efforts to bring medical device integration to Virtua, one of New Jersey’s largest non-profit, multi-hospital health systems.

Utilizing Bernoulli’s standards-based, open architecture Bernoulli One™ system enabled Virtua to bring medical device integration and connectivity across a complex healthcare ecosystem with an integrated, scalable, secure, and cost-effective web-based platform.

Virtua’s need for medical device integration and connectivity grew in part to free clinicians from writing out hundreds of patient data numbers from scores of different devices and machines every day in the course of care delivery. The health system wanted a plug-and-play medical connectivity paradigm that was uniform across different departments, could seamlessly interface with their Epic EHR, and could easily scale with the health system’s future growth.

With the conclusion of the Phase I integration in Virtua’s Perioperative Department, which includes Endoscopy, ECT and Interventional Radiology, the health system has realized complete electronic documentation, which has allowed clinicians to devote more of their time facing the patient and meeting their care needs.

Phase II will focus on Virtua’s Critical Care Unit, which includes the ICU and NICU/PICU, and will integrate the units’ physiological monitors, ventilators, anesthesia machines, smart tourniquets, and brain activity monitors.

Bernoulli One™, the company’s flagship platform, is the market’s only real-time, end-to-end, connected healthcare platform that combines comprehensive and vendor-agnostic medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, predictive analytics and robust distribution capabilities into one solution.

Bernoulli’s vectored event grid architecture enables true interoperability across disparate devices, networks, and systems by utilizing dynamically programmable intelligent appliances at the network edge. The system’s granular level of patient data detail, in real-time, at the point of care for improved decision support applications while also providing flexibility for user-defined configuration and control for device connectivity, monitoring and management, results in better allocation of personnel resources and reduced support costs.

Read the case study here and learn more about Bernoulli’s medical device integration and connectivity solutions here.

Be sure to also follow Bernoulli on LinkedIn and Twitter for the latest news and updates.

Bernoulli to Exhibit at 19th Annual NPSF Patient Safety Congress

Bernoulli to Exhibit at 19th Annual NPSF Patient Safety Congress - Booth 715

Bernoulli, the leader in real-time solutions for patient safety, will be exhibiting at Booth 715 at the 19th Annual NPSF Patient Safety Congress, May 17-19, 2017, at the Renaissance Orlando at SeaWorld hotel, Orlando, FL.

Bernoulli will be highlighting its capabilities in real-time data, medical device integration and patient safety solutions, as well as its latest application for the continuous monitoring of patients at risk of respiratory depression—Respiratory Depression Safety Surveillance (RDSS).

“Analysts have stressed the importance of hospitals providing the right information, at the right time, in the right format and to the right clinicians to enable real-time patient safety initiatives,” said Bernoulli CEO Janet Dillione. “The NPSF Congress us to engage with IT leaders on the frontlines, hear how they are approaching and adapting to healthcare’s rapidly changing landscape, and learn the real costs and considerations they face in finding a solution to their hospital’s unique challenges.”

RDSS utilizes comprehensive real-time data to help clinicians quickly recognize and respond to signs of respiratory distress. RDSS includes exclusive analytics with multi-variable thresholds—adjustable by the care facility—to identify clinically actionable events while significantly reducing the overall number of alarms communicated to remote and mobile clinicians, mitigating the risk of alarm fatigue.

The platform provides connectivity to a hospital’s existing fleet of pulse oximeters and capnographs from a wide range of vendors, including Medtronic, Masimo and others. RDSS also integrates with mobile clinical communication tools to deliver the right alarms and alerts to the right caregiver at the right time.

A forthcoming clinical study of patients diagnosed or at risk of obstructive or central sleep apnea, to be published in the Journal of Biomedical Instrumentation & Technology, the use of Bernoulli’s RDSS analytics reduced 22,812 alarms generated by bedside capnographs and pulse oximeters to just 209 respiratory depression alerts delivered to mobile clinicians—a reduction of 99%. More importantly, the RDSS analytics distributed alerts for every patient that experienced an actual respiratory depression episode.

Follow Bernoulli on LinkedIn and Twitter for additional updates, as well as access to case studies, thought leadership and other information.